CareValidate expanded its HRT offering for telehealth companies, combining hormone therapy with provider access, pharmacy ...
Fractyl Health reported positive six-month trial results from an investigation of its Revita procedure last week, but shares ...
The MATCH IT Act aims to reduce patient matching errors. But a model used by vital records systems could provide a better ...
Gilead Sciences is getting global rights to an experimental PepStar Therapeutics oral peptide designed to inhibit the IL-23 ...
MedTech Conference panelists cited inflammation research, listening to women, clinical trial representation and investment as ...
HealthTap launched a virtual care program to support sleep equipment suppliers and patients using PAP therapy.
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved ...
Vision products giant Alcon is expanding its offerings for the eyes through the $550 million acquisition of Neurotech Pharmaceuticals, a company that developed and commercialized the only FDA-approved ...
In addition to a packed conference agenda and tours of the Pegasus Park healthcare and life science innovation hub in Dallas, ...
Outro’s funding included participation from Listen Ventures, Cake Ventures, Jason Calicanis’s LAUNCH, Actions Capital, Hannah ...
The GSK cancer immunotherapy Jemperli is now approved for treating advanced cases of rectal cancer harboring a particular ...
Throwing more money at SDoH programs isn’t going to magically fix them. Instead, plans should be focusing on building out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results